Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma

Clinical trial NCT00003502 · WITHDRAWN

Trial details

NCT number: NCT00003502
Sponsor: Burzynski Research Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Contiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma Recurrent Mantle Cell Lymphoma

Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.